Stark COVID-19 Drug Shortages Warning From Senior EU Regulator
EMA Is Liaising With Firms On Potential Treatments And Vaccines
Executive Summary
The deputy head of the European Medicines Agency has outlined the steps the agency is taking to assess and address the possibility of drug shortages in Europe caused by the coronavirus outbreak, as the number of cases worldwide tops the 98,000 mark.
You may also be interested in...
Noël Wathion, Former EMA Deputy Executive Director, Dies Aged 66
The European Medicines Agency said Noël Wathion, who retired two years ago, will be remembered for steering the agency through challenges such as Brexit and COVID-19, in addition to being a champion of transparency and public engagement.
Decisive Action Called For On EU Drug Shortages
A public health advocacy group in the EU has issued tangible recommendations to address the perennial problem of drug shortages in the region.
EU Health Innovation Partnership Reflects Medtech’s Role In Unmet Needs
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.